These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

584 related articles for article (PubMed ID: 28164765)

  • 1. Commonalities in Biological Pathways, Genetics, and Cellular Mechanism between Alzheimer Disease and Other Neurodegenerative Diseases: An In Silico-Updated Overview.
    Ahmad K; Baig MH; Mushtaq G; Kamal MA; Greig NH; Choi I
    Curr Alzheimer Res; 2017; 14(11):1190-1197. PubMed ID: 28164765
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current Therapeutic Molecules and Targets in Neurodegenerative Diseases Based on in silico Drug Design.
    Sehgal SA; Hammad MA; Tahir RA; Akram HN; Ahmad F
    Curr Neuropharmacol; 2018; 16(6):649-663. PubMed ID: 29542412
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Physical Exercise-Induced Myokines in Neurodegenerative Diseases.
    Lee B; Shin M; Park Y; Won SY; Cho KS
    Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34071457
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The commonality of protein interaction networks determined in neurodegenerative disorders (NDDs).
    Limviphuvadh V; Tanaka S; Goto S; Ueda K; Kanehisa M
    Bioinformatics; 2007 Aug; 23(16):2129-38. PubMed ID: 17553855
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential of Therapeutic Small Molecules in Apoptosis Regulation in the Treatment of Neurodegenerative Diseases: An Updated Review.
    Dailah HG
    Molecules; 2022 Oct; 27(21):. PubMed ID: 36364033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protein misfolding in the late-onset neurodegenerative diseases: common themes and the unique case of amyotrophic lateral sclerosis.
    Mulligan VK; Chakrabartty A
    Proteins; 2013 Aug; 81(8):1285-303. PubMed ID: 23508986
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mitochondrial dynamics, a key executioner in neurodegenerative diseases.
    Panchal K; Tiwari AK
    Mitochondrion; 2019 Jul; 47():151-173. PubMed ID: 30408594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unraveling Molecular and Genetic Insights into Neurodegenerative Diseases: Advances in Understanding Alzheimer's, Parkinson's, and Huntington's Diseases and Amyotrophic Lateral Sclerosis.
    Ciurea AV; Mohan AG; Covache-Busuioc RA; Costin HP; Glavan LA; Corlatescu AD; Saceleanu VM
    Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37445986
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Panoramic Visualization of Circulating MicroRNAs Across Neurodegenerative Diseases in Humans.
    Brennan S; Keon M; Liu B; Su Z; Saksena NK
    Mol Neurobiol; 2019 Nov; 56(11):7380-7407. PubMed ID: 31037649
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exploring the Etiological Links behind Neurodegenerative Diseases: Inflammatory Cytokines and Bioactive Kynurenines.
    Tanaka M; Toldi J; Vécsei L
    Int J Mol Sci; 2020 Mar; 21(7):. PubMed ID: 32244523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Impact of Dysregulated microRNA Biogenesis Machinery and microRNA Sorting on Neurodegenerative Diseases.
    Weng YT; Chang YM; Chern Y
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834853
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advances in Applying Computer-Aided Drug Design for Neurodegenerative Diseases.
    Salman MM; Al-Obaidi Z; Kitchen P; Loreto A; Bill RM; Wade-Martins R
    Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33925236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Research on ferroptosis as a therapeutic target for the treatment of neurodegenerative diseases.
    Wang Y; Lv MN; Zhao WJ
    Ageing Res Rev; 2023 Nov; 91():102035. PubMed ID: 37619619
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Role of Long Noncoding RNAs in Neurodegenerative Diseases.
    Wan P; Su W; Zhuo Y
    Mol Neurobiol; 2017 Apr; 54(3):2012-2021. PubMed ID: 26910817
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting New Candidate Genes by Small Molecules Approaching Neurodegenerative Diseases.
    Fan HC; Chi CS; Cheng SN; Lee HF; Tsai JD; Lin SZ; Harn HJ
    Int J Mol Sci; 2015 Dec; 17(1):. PubMed ID: 26712747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic and Therapeutic Potential of Exosomal MicroRNAs for Neurodegenerative Diseases.
    He M; Zhang HN; Tang ZC; Gao SG
    Neural Plast; 2021; 2021():8884642. PubMed ID: 34054944
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stalling the Course of Neurodegenerative Diseases: Could Cyanobacteria Constitute a New Approach toward Therapy?
    Ramos V; Reis M; Ferreira L; Silva AM; Ferraz R; Vieira M; Vasconcelos V; Martins R
    Biomolecules; 2023 Sep; 13(10):. PubMed ID: 37892126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting mTORs by omega-3 fatty acids: A possible novel therapeutic strategy for neurodegeneration?
    Shirooie S; Nabavi SF; Dehpour AR; Belwal T; Habtemariam S; Argüelles S; Sureda A; Daglia M; Tomczyk M; Sobarzo-Sanchez E; Xu S; Nabavi SM
    Pharmacol Res; 2018 Sep; 135():37-48. PubMed ID: 29990625
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Telomerase reverse transcriptase and neurodegenerative diseases.
    Yu X; Liu MM; Zheng CY; Liu YT; Wang Z; Wang ZY
    Front Immunol; 2023; 14():1165632. PubMed ID: 37063844
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyanobacteria, Cyanotoxins, and Neurodegenerative Diseases:
    Sini P; Dang TBC; Fais M; Galioto M; Padedda BM; Lugliè A; Iaccarino C; Crosio C
    Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445429
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.